Wuhan ZhongBoLvya Biotechnology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Wuhan ZhongBoLvya Biotechnology Co., Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 6 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include P1000, BIO1000, SMARTBIO, SMART1000, and SMARTHERB. The owner is based in WUHAN,HUBEI PROVINCE.
NO. 555 WENHUA AVENUE, HONGSHAN DISTRICT
A17-5, RAYCOM SMART VALLEY
WUHAN,HUBEI PROVINCE 430072 , CN
Showing of trademarks Trademarks
Trademark Classifications
Wuhan ZhongBoLvya Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Wuhan ZhongBoLvya Biotechnology Co., Ltd. have?
Wuhan ZhongBoLvya Biotechnology Co., Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned.
What trademark classes does Wuhan ZhongBoLvya Biotechnology Co., Ltd. file in?
Wuhan ZhongBoLvya Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 31 (Natural Agricultural Products). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are Wuhan ZhongBoLvya Biotechnology Co., Ltd.'s most well-known trademarks?
Wuhan ZhongBoLvya Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as P1000, BIO1000, SMARTBIO, SMART1000, and SMARTHERB. These are among 5 currently registered trademarks in the portfolio.
What is Wuhan ZhongBoLvya Biotechnology Co., Ltd.'s trademark registration success rate?
Wuhan ZhongBoLvya Biotechnology Co., Ltd. has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.